Healthy Volunteers Clinical Trial
Official title:
Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities
This study will evaluate new assessment tools and equipment and new ways of using existing
tools and equipment in the NIH Clinical Center s Rehabilitation Medicine Department in order
to maximize patients function. The Department assesses and treats NIH patients with chronic
pain, problems in walking or getting around, activities of daily living, performing tasks
needed for jobs or hobbies, communicating and chewing and swallowing.
Children and adults of all ages with disabilities and healthy normal volunteers may be
eligible for this study.
The following kinds of assessments are evaluated in this study:
Assessments of Impairments
Impairments are problems such as loss of movement, weakness or loss of sensation. Assessments
may include measurements of range of motion, strength, sensation, pain, joint stability or
mobility, joint angles, limb and girth, gait, exercise tolerance, stamina, or ultrasound
imaging of muscle and swallowing function.
Assessments of Function and Performance
Functional and performance assessments look at how well subjects perform actions, such as
walking or getting around, dressing, or preparing meals. They may include evaluations of
activities of daily living, leisure activities, fatigue, vocational activity, school
activity, coping skills, and quality of life. The assessments may be done by questionnaires
or interviews and by watching subjects perform the activities.
Assessments of Treatment Techniques
Treatment techniques are assessed by evaluating methods and equipment used to treat patients
with impairments or problems with function. They may evaluate, for example, the use of heat,
cold, strengthening exercises, fitness exercises, TENS units, splinting and orthotics, or
shoe modifications.
Objective
The objective of the protocol is to provide framework in which clinicians in the Department
of Rehabilitation Medicine (RMD) can serve the clinical needs of patients and the intramural
clinical research needs of NIH investigators by maintaining state of the art expertise in the
functional assessment of persons with disabilities and investigating new equipment,
methodologies and/or techniques for functional assessment.
Study Population
We intend to study a total of 500 healthy volunteers and 500 subjects with disabilities,
including those enrolled in NIH intramural research protocols.
Design
The study will consist of individual projects designed designed by RMD staff including one or
more of the associate investigators. The individual projects will be relatively small and
designed to test the reliability, reproducibility, efficiency, feasibility, sensitivity,
specificity, tolerability, validity and/or precision of physical medicine and rehabilitation
assessment equipment, devices and clinical evaluations of impairment, disability, and/or
function.
Outcome Measures
The specific outcome measure(s) will be chosen to meet the goals of the individual project
and will generally include one or more of the following:
i. Subjective assessment by the participant of the test, device, or evaluation based on
written evaluation tools.
ii. Comparisons to established evaluations or equipment designed to assess similar areas of
function, including concurrent validity analyses.
iii. Subjective assessment by clinicians using the test, device or evaluation, based on
written evaluation tools.
iv. Feasibility assessments, including the time required for participants to perform tests,
time for clinicians to evaluate the results of the tests, and/or prepare reports of the
results of tests.
v. Assessments of reliability and/or stability of the technique used, including statistical
tests of coefficients of variability.
vi. Assessments of tolerance of tests, including measures such as vital signs or elements of
a physical examination.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |